Coronavirus Resources

New COVID-19 Treatment Can Help Keep Patients Out of the Hospital

Choose the health content that’s right for you, and get it delivered right in your inbox.

Those newly diagnosed with COVID-19 now have easier access to a treatment that can help them recover faster without needing to be hospitalized. 

With a simple 30-minute infusion, monoclonal antibody therapy is the only treatment currently available in the U.S. that’s been proven to help COVID-19 patients in the outpatient setting, before they get severely ill from the virus. 

“Studies show it is important patients receive this treatment as early as possible after getting COVID-19 to help reduce the amount of virus in the body, improve symptoms sooner, and make it less likely to be admitted to a hospital,” explains AdventHealth infectious disease specialist Dr. Vincent Hsu.

And the good news is, AdventHealth has several outpatient clinics conveniently located throughout Central Florida to make it easier for patients to get access to this potentially life-saving treatment. 

“Monoclonal antibodies are an effective but underutilized therapy to reduce COVID-19 severity in high-risk patients,” Hsu said.

Antibodies are made by the immune system to fight the virus, but it takes weeks after infection for them to form. This treatment uses lab-made versions of antibodies that can help right away and it became more widely known after President Donald Trump received this type of therapy after contracting COVID-19 in Oct. 2020.

The monoclonal antibody therapies now available at AdventHealth’s outpatient clinics include:

Who is a candidate?
Monoclonal antibody therapy is not for everyone, but the good news is, the Food and Drug Administration (FDA) recently updated the criteria to include almost anyone deemed appropriate by a physician. This includes patients 65 and older, anyone overweight or obese, those with hypertension or diabetes, patients who are pregnant, and many other medical conditions or factors (such as race or ethnicity).

Monoclonal antibodies are authorized for treating mild-to-moderate COVID-19 in adults and pediatric patients (age 12 & older) with positive results of COVID-19, and who are at risk for progressing to severe COVID-19 and/or hospitalization. Anyone who meets any of the following conditions or criteria is a candidate for this treatment:

  • Older age (≥ 65 years)
  • Obesity or overweight
  • Diabetes
  • Cardiovascular disease (for example, high blood pressure)
  • Pregnancy
  • Chronic lung diseases
  • Chronic kidney disease
  • Immunosuppressive disease or treatment
  • Sickle cell disease
  • Neurodevelopmental disorders
  • Medical-related technological dependence
  • Other medical conditions or factors (for example, race or ethnicity)

How can I (or my loved one) get this treatment?
AdventHealth offers monoclonal antibody therapies at outpatient clinic locations in Central Florida, located in Lake County (Tavares), Orange County (Orlando) and Volusia County (Orange City). However, a physician order is required for patients to receive this treatment. 

Community members with questions about monoclonal antibody therapy can call the AdventHealth Coronavirus Information Line at 877-VIRUS-HQ Call877-847-8747).  

Recent Blogs

blood drive_Gordon
Schedule Publish Test
Michael- Genomics Patient
Testing Schedule
The Delta Variant: Here’s What We Know
A gentleman showing an e-ticket to a flight teller
Travel and Transit Considerations for Summer Travel
The 5 Vaccines Every Person Over Age 65 Should Consider
View More Articles